Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord MSC Conditioned Media for Knee Osteoarthritis
NCT06688318Phase 2Active, not recruiting
- Sponsor
- National Research and Innovation Agency
- Start
- Apr 2024
- Primary completion
- Sep 2024
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human umbilical cord mesenchymal stem cell secretome in osteoarthritis (OA), sponsored by National Research and Innovation Agency. Primary endpoints: Knee Injury and Osteoarthritis Outcome Score at 6 months, Knee Society Score at 6 months and 1 more. Started Apr 2024; status: active, not recruiting.
02
Drugs
human umbilical cord mesenchymal stem cell secretome
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06688318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06688318.